Clinical Trials for HaiHe Biopharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: HaiHe Biopharma

Clinical Trials (4)

NCT06975618
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)
PHASE1/PHASE2Recruiting
141 participants
Started: Aug 22, 2023 · Completed: Dec 31, 2029
2 conditions1 sponsor4 locations
NCT06909877
Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
PHASE1/PHASE2Recruiting
100 participants
Started: Jul 27, 2022 · Completed: Jul 30, 2027
1 condition1 sponsor1 location
NCT04390737
Evaluate the Safety and Clinical Activity of HH2853
PHASE1/PHASE2Recruiting
254 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2025
4 conditions1 sponsor25 locations
NCT04270591
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
PHASE1/PHASE2Recruiting
183 participants
Started: Jul 15, 2019 · Completed: Dec 30, 2023
1 condition1 sponsor44 locations